Nextremity Solutions announced that it has received clearance from the U.S. Food and Drug Administration and CE Mark certification for its MSP Metatarsal Shortening Plate and System.
The system is positioned for metatarsal shortening osteotomies to correct toe angulation/dislocation and relieve pressure. The company will prepare for a limited product release in the coming weeks.
Nextremity Solutions is a privately held medical device company offering solutions and approaches to forefoot surgical intervention.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018